Early Life Social Stress Causes Sex- and Region-Dependent Dopaminergic Changes that Are Prevented by Minocycline

Mol Neurobiol. 2022 Jun;59(6):3913-3932. doi: 10.1007/s12035-022-02830-6. Epub 2022 Apr 18.

Abstract

Early life stress (ELS) is known to modify trajectories of brain dopaminergic development, but the mechanisms underlying have not been determined. ELS perturbs immune system and microglia reactivity, and inflammation and microglia influence dopaminergic transmission and development. Whether microglia mediate the effects of ELS on dopamine (DA) system development is still unknown. We explored the effects of repeated early social stress on development of the dopaminergic system in male and female mice through histological, electrophysiological, and transcriptomic analyses. Furthermore, we tested whether these effects could be mediated by ELS-induced altered microglia/immune activity through a pharmacological approach. We found that social stress in early life altered DA neurons morphology, reduced dopamine transporter (DAT) and tyrosine hydroxylase expression, and lowered DAT-mediated currents in the ventral tegmental area but not substantia nigra of male mice only. Notably, stress-induced DA alterations were prevented by minocycline, an inhibitor of microglia activation. Transcriptome analysis in the developing male ventral tegmental area revealed that ELS caused downregulation of dopaminergic transmission and alteration in hormonal and peptide signaling pathways. Results from this study offer new insight into the mechanisms of stress response and altered brain dopaminergic maturation after ELS, providing evidence of neuroimmune interaction, sex differences, and regional specificity.

Keywords: Early life stress; Microglia; RNA sequencing; Sex differences; Substantia nigra; Ventral tegmental area.

MeSH terms

  • Age Factors
  • Animals
  • Dopaminergic Neurons* / metabolism
  • Female
  • Male
  • Mice
  • Minocycline* / pharmacology
  • Sex Factors
  • Stress, Psychological*
  • Substantia Nigra / pathology
  • Tyrosine 3-Monooxygenase / metabolism
  • Ventral Tegmental Area / metabolism

Substances

  • Tyrosine 3-Monooxygenase
  • Minocycline